Search details
1.
Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element.
Cell
; 173(6): 1398-1412.e22, 2018 05 31.
Article
in English
| MEDLINE | ID: mdl-29731168
2.
The Mettl3 epitranscriptomic writer amplifies p53 stress responses.
Mol Cell
; 82(13): 2370-2384.e10, 2022 07 07.
Article
in English
| MEDLINE | ID: mdl-35512709
3.
Deterministic evolution and stringent selection during preneoplasia.
Nature
; 618(7964): 383-393, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-37258665
4.
Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression Program.
Mol Cell
; 80(3): 452-469.e9, 2020 11 05.
Article
in English
| MEDLINE | ID: mdl-33157015
5.
Inter-cellular CRISPR screens reveal regulators of cancer cell phagocytosis.
Nature
; 597(7877): 549-554, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34497417
6.
The AMBRA1 E3 ligase adaptor regulates the stability of cyclin D.
Nature
; 592(7856): 794-798, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33854239
7.
CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilities.
Nature
; 580(7801): 136-141, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32238925
8.
Serine starvation silences estrogen receptor signaling through histone hypoacetylation.
Proc Natl Acad Sci U S A
; 120(38): e2302489120, 2023 09 19.
Article
in English
| MEDLINE | ID: mdl-37695911
9.
Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups.
Nature
; 567(7748): 399-404, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30867590
10.
The m6A RNA demethylase FTO is a HIF-independent synthetic lethal partner with the VHL tumor suppressor.
Proc Natl Acad Sci U S A
; 117(35): 21441-21449, 2020 09 01.
Article
in English
| MEDLINE | ID: mdl-32817424
11.
Patient perspectives on window of opportunity clinical trials in early-stage breast cancer.
Breast Cancer Res Treat
; 194(1): 171-178, 2022 Jul.
Article
in English
| MEDLINE | ID: mdl-35538268
12.
The breast cancer oncogene EMSY represses transcription of antimetastatic microRNA miR-31.
Mol Cell
; 53(5): 806-18, 2014 03 06.
Article
in English
| MEDLINE | ID: mdl-24582497
13.
Transcriptome and genome evolution during HER2-amplified breast neoplasia.
Breast Cancer Res
; 23(1): 73, 2021 07 15.
Article
in English
| MEDLINE | ID: mdl-34266469
14.
Harnessing Tumor Evolution to Circumvent Resistance.
Trends Genet
; 34(8): 639-651, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29903534
15.
A population genetics perspective on the determinants of intra-tumor heterogeneity.
Biochim Biophys Acta Rev Cancer
; 1867(2): 109-126, 2017 Apr.
Article
in English
| MEDLINE | ID: mdl-28274726
16.
Organoids reveal cancer dynamics.
Nature
; 556(7702): 441-442, 2018 04.
Article
in English
| MEDLINE | ID: mdl-29686366
17.
The shaping and functional consequences of the microRNA landscape in breast cancer.
Nature
; 497(7449): 378-82, 2013 May 16.
Article
in English
| MEDLINE | ID: mdl-23644459
18.
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.
Nature
; 486(7403): 346-52, 2012 Apr 18.
Article
in English
| MEDLINE | ID: mdl-22522925
19.
The clonal and mutational evolution spectrum of primary triple-negative breast cancers.
Nature
; 486(7403): 395-9, 2012 Apr 04.
Article
in English
| MEDLINE | ID: mdl-22495314
20.
The Breast Cancer Oncogene EMSY Represses Transcription of Antimetastatic microRNA miR-31.
Mol Cell
; 54(1): 203, 2014 Apr 10.
Article
in English
| MEDLINE | ID: mdl-28898635